LUX-Lung 7: Phase 2b trial of first-line afatinib versus gefitinib for EGFR mutation-positive NSCLC
For scientific research only, not for patients.
Product Detail
Product Tags
| Pack Size | Availability | Price (USD) |
Chemical Name:
SMILES Code:
InChi Code:
InChi Key:
Keyword:
Solubility:
Storage:
Description:
Target: